Nanostructures as promising tools for delivery of antimicrobial peptides

Mini-Reviews in Medicinal Chemistry

Volumn 12, Issue 8, 2012, Pages 731-741

  Brandelli, A ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Antimicrobial; Bacteriocin; Bioactive peptides; Drug delivery; Encapsulation; Liposome; Nanoparticle; Nanostructure

Indexed keywords

AMPHOTERICIN B; BACTERIOCIN; BETA DEFENSIN; CARBON NANOTUBE; CECROPIN A; CIPROFLOXACIN; CYCLOSPORIN A; DEXAMETHASONE; EPIDERMIN; GELATIN; ITURIN A; MAGAININ 1; METAL NANOPARTICLE; NANOCOATING; NANOFIBER; NANOMATERIAL; NANOSPHERE; OCTREOTIDE; PACLITAXEL; POLYACRYLIC ACID; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIC ACID; POLYMER; POLYPEPTIDE ANTIBIOTIC AGENT; POLYVINYL ALCOHOL; SILVER NANOPARTICLE; SINGLE WALLED NANOTUBE;

ADSORPTION; ALPHA HELIX; AMINO ACID SEQUENCE; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BACILLUS; BACILLUS AMYLOLIQUEFACIENS; BACTERIAL GROWTH; BETA SHEET; BIOCOMPATIBILITY; BIODEGRADATION; BIOMECHANICS; BLOOD BRAIN BARRIER; BREAST TUMOR; CONTROLLED RELEASE FORMULATION; CRYPTOCOCCUS NEOFORMANS; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG STABILITY; ELASTICITY; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; HYDROGEL; HYDROGENATION; IN VITRO STUDY; IN VIVO STUDY; LACTIC ACID BACTERIUM; LACTOBACILLUS SAKEI; LIPID COMPOSITION; LIPID VESICLE; LISTERIA MONOCYTOGENES; MEMBRANE PERMEABILITY; MENINGITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICELLE; MICROCOCCUS LUTEUS; NANOENCAPSULATION; NONHUMAN; PH; PROTEIN ASSEMBLY; PROTEIN BINDING; REVIEW; SOLUBILIZATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; VIRUS ATTACHMENT; WOUND HEALING;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; NANOSTRUCTURES; NANOTECHNOLOGY;

EID: 84862632081     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955712801264774     Document Type: Review

References (104)

1. Shrivastava, S.; Dash, D. Applying nanotechnology to human health: revolution in biomedical sciences. J. Nanotechnol., 2009, doi:10.1155/2009/184702.
2. Mozafari, M.R. Nanomaterials and nanosystems for biomedical applications; Springer: Dordrecht, 2007.
3. Santos-Magalhães, N.S.; Mosqueira, V.C.F. Nanotechnology applied to the treatment of malaria. Adv. Drug Deliv. Rev., 2010, 62, 560-575.
4. Sanguansri, P.; Augustin, M.A. Nanoscale materials development-a food industry perspective. Trends Food Sci. Technol., 2006, 17, 547-556.
5. Chew, S.Y.; Wen, J.; Yim, E.K.F.; Leong, K.W. Sustained release of proteins from electrospun biodegradable fibers. Biomacromolecules, 2005, 6, 2017-2024.
6. Tammaro, L.; Costantino, U.; Bolognese, A.; Sammartino, G; Marenzi, G.; Calignano, A.; Tefè, S.; Mastrangelo, F.; Califano, L.; Vittoria, V. Nanohybrids for controlled antibiotic release in topical applications. Int. J. Antimicrob. Agents, 2007, 29, 417-423.
7. Rangari, V.K.; Mohammad, G.M.; Jeelani, S.; Hundley, A.; Vig, K.; Singh, S.R.; Pillai, S. Synthesis of Ag/CNT hybrid nanoparticles and fabrication of their Nylon-6 polymer nanocomposite fibers for antimicrobial applications. Nanotechnology, 2010, 21, 095102.
8. Soppimath, K.S.; Aminabhavi, T.M.; Kulkarni, A.R.; Rudzinski, W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release, 2001, 70, 1-20.
9. Reis, C.P.; Neufeld, R.J.; Ribeiro, A.J.; Veiga, F. Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems. Nanomedicine, 2006, 2, 53-65.
10. Yadav, S.C.; Kumari, A.; Yadav, R. Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation. Peptides, 2011, 32, 173-187.
11. Heunis, T.D.J.; Dicks, L.M.T. Nanofibers offers alternative ways to the treatment of skin infections. J. Biomed. Biotechnol., 2010, doi: 10.1155/2010/510682.
12. Bianco, A.; Kostarelos, K.; Prato, M. Applications of carbon nanotubes in drug delivery. Curr. Op. Chem. Biol., 2005, 9, 674-679.
13. Eby, D.M.; Luckarift, H.R.; Johnson, G.R. Hybrid antimicrobial enzyme and silver nanoparticle coatings for medical instruments. ACS Appl. Mat. Interfaces, 2009, 1, 1553-1560.
14. Liu, Z.; Chen, K.; Davis, C.; Sherlock, S.; Cao, Q.; Chen, X.; Dai, H. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res., 2008, 68, 6652-6660.
15. Abidian, M.R.; Kim, D.H.; Martin, D.C. Conducting-polymer nanotubes for controlled drug release. Adv. Mat., 2008, 18, 405-409.
16. Anderson, D.G.; Burdick, J.A.; Langer, R. Materials science. Smart biomaterials. Science, 2004, 305, 1923-1924.
17. Hashida, M.; Kawakami, S.; Yamashita, F. Lipid carrier systems for targeted drug and gene delivery. Chem. Pharmac. Bull., 2005, 53, 871-880.
18. Hwang, P.M., Vogel, H.J. Structure-function relationships of antimicrobial peptides. Biochem. Cell Biol., 1998, 76, 235-246.
19. Oyston, P.C.F.; Fox, M.A.; Richards, S.J.; Clark G.C. Novel peptide therapeutics for treatment of infections. J. Med. Microbiol., 2009, 58, 977-987.
20. Powers, J.P.S.; Hancock, R.E.W. The relationship between peptide structure and antibacterial activity. Peptides, 2003, 24, 1681-1691.
21. Hancock, R.E.W.; Sahl, H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nature Biotechnol., 2006, 24, 1551-1557.
22. Benitez, L.B.; Caumo K.; Brandelli, A; Rott, M.B. Bacteriocin-like substance from Bacillus amyloliquefaciens shows remarkable inhibition of Acanthamoeba polyphaga. Parasitol. Res., 2011, 108, 687-691.
23. Reddy, K.V.R.; Yedery, R.D.; Aranha, C. Antimicrobial peptides: premises and promises. Int. J. Antimicrob. Agents, 2004, 24, 536-547.
24. Bower, C.K.; Parker, J.E.; Higgins, A.Z.; Oest, M.E.; Wilson, B.A.; Valentine, B.A.; Bothwell, M.K.; McGuire, J. Protein antimicrobial barriers to bacterial adhesion: in vitro and in vivo evaluation of nisin-treated implantable materials. Colloids and Surfaces B: Biointerfaces, 2002, 25, 81-90.
25. Fontana, M.B.C.; Bastos, M.C.F.; Brandelli, A. Bacteriocins Pep5 and epidermin inhibit Staphylococcus epidermidis adhesion to catheters. Curr. Microbiol., 2006, 52, 350-353.
26. Moon, J.Y.; Henzler-Wildman, K.A.; Ramamoorthy, A. Expression and purification of a recombinant LL-37 from Escherichia coli. Biochim. Biophys. Acta, 2006, 1758, 1351-1358.
27. Dholpe, V.; Krukemeyer, A.; Ramammorthy, A. The human beta-defensin-3, an antibacterial peptide with multiple biological functions. Biochim. Biophys. Acta, 2006, 1758, 1499-1512.
28. Riley, M.A; Wertz, J.E. Bacteriocin diversity: ecological and evolutionary perspectives. Biochimie, 2002, 84, 357-364.
29. Motta, A.S.; Brandelli, A. Properties and antimicrobial activity of the smear surface cheese coryneform bacterium Brevibacterium linens. Eur. Food Res. Technol., 2009, 227, 1219-1306.
30. Stein, T. 2005. Bacillus subtilis antibiotics: structures, syntheses and specific functions. Mol. Microbiol., 2005, 56, 845-857.
31. Oscáriz, J.C.; Cintas, L.; Holo, H., Lasa, I.; Nes, I.F.; Pisabarro, A.G. Purification and sequencing of cerein 7B, a novel bacteriocin produced by Bacillus cereus. FEMS Microbiol. Lett., 2006, 254, 108-115.
32. Kawulka, K.E.; Sprules, T.; Diaper, C.M.; Whittal, R.M.; Mackay, R.T.; Mercier, P.; Zuber, P.; Vederes, J.C. Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to α-carbon cross-link: formation and reduction of a α-thio-α-amino acid derivatives. Biochemistry, 2004, 43, 3385-3395.
33. Tamehiro, N.; Okamoto-Hosoya, Y.; Okamoto, S.; Ubukata, M.; Hamada, M.; Naganawa, H.; Ochi, K. Bacilysocin, a novel phospholipid antibiotic produced by Bacillus subtilis 168. Antimicrob. Agents Chemother., 2002, 46, 315-320.
34. Cleveland, J.; Montville, T.J.; Nes, I.F.; Chikindas, M.L. Bacteriocins: safe, natural antimicrobials for food preservation. Int. J. Food Microbiol., 2001, 71, 1-20.
35. Deegan, L.H.; Cotter, P.D.; Hill, C.; Ross, P. Bacteriocins: biological tools for bio-preservation and shelf-life extension. Int. Dairy J., 2006, 16, 1058-1071.
36. Malheiros, P.S.; Daroit, D.J.; Brandelli, A. Food applications of liposome-encapsulated antimicrobial peptides. Trends Food Sci. Technol., 2010, 21, 284-292.
37. Couvreur, P.; Dubernet, C.; Puisieux, F. Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur. J. Pharmaceut. Biopharmaceut., 1995, 42, 2-13.
38. El-Shabouri, M.H. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin A. Int. J. Pharmaceut., 2002, 249, 101-108.
39. Kommareddy, S.; Amiji, M. Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice. J. Pharmac. Sci., 2007, 96, 397-407.
40. Jain, D.;Banerjee, R. Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery. J. Biomed. Mat. Res. B, 2008, 86B, 105-112.
41. Satishkumar, R.; Vertegel, A. Charge-directed targeting of antimicrobial protein-nanoparticle conjugates. Biotechnol. Bioeng., 2008, 100, 403-412.
42. Sant'Anna, V.; Malheiros, P.S.; Brandelli, A. Liposome encapsulation protects bacteriocin-like substance P34 against inhibition by Maillard reaction products. Food Res. Int., 2011, 44, 326-330.
43. Bi, L.; Yang, L.; Narsimhan, G.; Bhunia, A.K.; Yao, Y. Designing carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptide. J. Control. Release, 2011, 150, 150-156.
44. Khosravi-Darani, K.; Pardakhty, A.; Honarpisheh, H.; Rao, V.S.N.M.; Mozafari, M.R. The role of high-resolution imaging in the evaluation of nanovesicles for bioactive encapsulation and targeted nanotherapy. Micron, 2007, 38, 804-818.
45. Mozafari, M.R.; Johnson, C.; Hatziantoniou, S.; Demetzos, C. Nanoliposomes and their applications in food nanotechnology. J. Liposome Res., 2008, 18, 309-327.
46. Mozafari, M.R. Liposomes: an overview of manufacturing techniques. Cel. Mol. Biol. Lett., 2005, 10, 711-719.
47. Jesorka, A.; Orwar, O. Liposomes: technologies and analytical applications. Annu. Rev. Anal. Chem., 2008, 1, 801-832.
48. Sharma, A.; Sharma, U.S. Liposomes in drug delivery: progress and limitations. Int. J. Pharmaceut., 1997, 154, 123-140.
49. Teixeira, M.L.; Santos, J.; Silveira, N.P.; Brandelli, A. Phospholipid nanovesicles containing a bacteriocin-like substance for control of Listeria monocytogenes. Innov. Food Sci. Emerg. Technol., 2008, 9, 49-53.
50. Malheiros, P.S.; Micheletto, Y.M.S., Silveira, N.P.; Brandelli, A. Development and characterization of phosphatidylcholine nanovesicles containing the antimicrobial peptide nisin. Food Res. Int., 2010, 43, 1198-1203.
51. Malheiros, P.S.; Daroit, D.J.; Silveira, N.P.; Brandelli, A. Effect of nanovesicle-encapsulated nisin on growth of Listeria monocytogenes in milk. Food Microbiol., 2010, 27, 175-178.
52. Were, L.M.; Bruce, B.D.; Davidson, M.; Weiss, J. Size, stability, and entrapment efficiency of phospholipids nanocapsules containing polypeptide antimicrobials. J. Agric. Food Chem., 2003, 51, 8073-8079.
53. Taylor, T.M.; Bruce, B.D.; Weiss, J.; Davidson, P.M. Listeria monocytogenes and Escherichia coli O157:H7 inhibition in vitro by liposome-encapsulated nisin and ethylene diaminetetraacetic acid. J. Food Saf., 2008, 28, 183-197.
54. Laridi, R.; Kheadr, E.E.; Benech, R.O.; Vuillemard, J.C.; Lacroix, C.; Fliss, I. Liposome encapsulated nisin Z: optimization, stability and release during milk fermentation. Int. Dairy J., 2003, 13, 325-336.
55. Mugabe, C.; Halwani, M.; Azghani, A.O.; Lafrenie, R.M.; Omri, A. Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 2006, 50, 2016-2022.
56. Colas, J.C.; Shi, W.; Rao, V.S.N.M.; Omri, A.; Mozafari, M.R.; Singh, H. Microscopical investigations of nisin-loaded nanoliposomes prepared by Mozafari method and their bacterial targeting. Micron, 2007, 38, 841-847.
57. Richardson, A.; de Antueno, R.; Duncan, R.; Hoskin, D.W. Intracellular delivery of bovine lactoferricin's antimicrobial core (RRWQWR) kill T-leukemia cells. Biochem. Biophys. Res. Commun., 2009, 388, 736-741.
58. Malheiros, P.S.; Sant'Anna, V.; Micheletto, Y.M.S.; Silveira, N.P.; Brandelli, A. Nanovesicle encapsulation of antimicrobial peptide P34: Physicochemical characterization and mode of action on Listeria monocytogenes. J. Nanoparticle Res., 2011, 13, 3545-3552.
59. Were, L.M.; Bruce, B.; Davidson, P.M.; Weiss, J. Encapsulation of nisin and lysozyme in liposomes enhances efficacy against Listeria monocytogenes. J. Food Protec., 2004, 67, 922-927.
60. El Jastimi, R.; Lafleur, M. Nisin promotes the formation of non-lamellar inverted phases in unsaturated phosphatidylethanolamines. Biochim. Biophys. Acta, 1999, 1418, 97-105.
61. El Jastimi, R.; Edwards, K.; Lafleur, M. Characterization of permeability and morphological perturbations induced by nisin on phosphatidylcholine membranes. Biophys. J., 1999, 77, 842-852.
62. Zhao, H.; Kinnunen, P.K.J. Binding of the antimicrobial peptide temporin L to liposomes assessed by Trp fluorescence. J. Biol. Chem., 2002, 277, 25170-25177.
63. Choi, M.J.; Kang, S.H.; Kim, S.; Chang, J.S.; Kim, S.S.; Cho, H.; Lee, K.H. The interaction of an antimicrobial decapeptide with phospholipid vesicles. Peptides, 2004, 25, 675-683.
64. Zhao, H.; Sood, R.; Jutila, A.; Bose, S.; Fimland, G.; Nissen-Meyer, J.; Kinnunen, P.K.J. Interaction of the antimicrobial peptide pheromone plantaricin A with model membranes: implications for a novel mechanism of action. Biochim. Biophys. Acta, 2006, 1758, 1464-1474.
65. Verly, R.M.; Rodrigues, M.A.; Daghastanli, K.R.P.; Denadai, A.M.L.; Cuccovia, I.M.; Bloch Jr., C.; Frézard, F.; Santoro, M.M.; Piló-Veloso, D.; Bemquerer, M.P. Effect of cholesterol on the interaction of the amphibian antimicrobial peptide DDK with liposomes. Peptides, 2008, 29, 15-24.
66. Liu, W.; Hansen, J.N. Some chemical and physical properties of nisin, a small-protein antibiotic produced by Lactococcus lactis. Appl. Environ. Microbiol., 1990, 56, 2551-2558.
67. Taylor, T.M.; Gaysinsky, S.; Davidson, P.M.; Bruce, B.D.; Weiss, J. Characterization of antimicrobial-bearing liposomes by ζ-potential, vesicle size, and encapsulation efficiency. Food Biophys., 2007, 2, 1-9.
68. Huang, Z.M.; Zhang, Y.Z.; Kotaki, M.; Ramakrishna, A. A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Composites Sci. Technol., 2003, 63, 2223-2253.
69. Yoo, H.S.; Kim, T.G.; Park, T.G. Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery. Adv. Drug Deliv. Rev., 2009, 61, 1033-1042.
70. Pham, Q.P.; Sharma, U.; Mikos, A.G. Electrospinning of polymeric nanofibers for tissue engineering applications: a review. Tissue Eng., 2006, 12, 1197-1211.
71. Yang, D.; Li, Y.; Nie, J. Preparation of gelatin/PVA nanofibers and their potential application in controlled release of drugs. Carbohydr. Polym., 2007, 69, 538-543.
72. Maretschek, S.; Greiner, A.; Kissel, T. Electrospun biodegradable nanofiber nonwovens for controlled release of proteins. J. Control. Release, 2008, 127, 180-187.
73. Kim, T.G.; Lee, D.S.; Park, T.G. Controlled protein release from electrospun biodegradable fiber mesh composed of poly(ε-caprolactone) and poly(ethylene oxide). Int. J. Pharmaceut., 2007, 338, 276-283.
74. Rudra, J.S.; Dave, K.; Haynie, D.T. Antimicrobial polypeptide multilayer nanocoatings. J. Biomat. Sci.-Polym. Ed., 2006, 17, 1301-1315.
75. Heunis, T.D.J; Botes, M.; Dicks, L.M.T. Encapsulation of Lactobacillus plantarum 423 and its bacteriocin in nanofibers. Probiotics Antimicrob. Prot., 2010, 2, 46-51.
76. Salmaso, S.; Elvassore, N.; Bertucco, A.; Lante, A.; Caliceti, P. Nisin-loaded poly-L-lactide nano-particles produced by CO2 anti-solvent precipitation for sustained antimicrobial activity. Int. J. Pharmaceut., 2004, 287, 163-173.
77. Schneider, A.; Garlick, J.A.;Egles, C. Self-assembling peptide nanofiber scaffolds accelerate wound healing. PLoS ONE, 2008, 3, e1410, doi: 10.1371/journal.pone.0001410.
78. Bai, L.; Zhu, L.; Min, S.; Liu, L.; Cai, Y.; Yao, J. Surface modification and properties of Bombyx mori silk fibroin films by antimicrobial peptide. Appl. Surface Sci., 2008, 254, 2988-2995.
79. Yao, C.; Li, X.S.; Neoh, K.G.; Shi, Z.L.; Kang, E.T. Surface modification and antibacterial activity of electrospun polyurethane fibrous membranes with quaternary ammonium moieties. J. Membr. Sci., 2008, 320, 259-267.
80. Sun, X.Y.; Shankar, R.; Borner, H.G.; Ghosh, T.K., Spontak, R.J. Field-driven biofunctionalization of polymer fiber surfaces during electrospinning. Adv. Biomat., 2007, 19, 87-91.
81. Sharma, V.K.; Yngard, R.A.; Lin, Y. Silver nanoparticles: Green synthesis and their antimicrobial activities. Adv. Colloid Interface Sci., 2009, 145, 83-96.
82. Chen, G.; Zhou, M.; Chen, S.; Lv, G.; Yao, J. Nanolayer biofilm coated on magnetic nanoparticles by using a dielectric barrier discharge glow plasma fluidized bed for immobilizing an antimicrobial peptide. Nanotechnology, 2009, 20, 465706.
83. Dias, A.M.G.C.; Hussain, A.; Marcos, A.S.; Roque, A.C.A. A biotechnological perspective on the application of iron oxide magnetic colloids modified with polysaccharides. Biotechnol. Adv., 2011, 29, 142-155.
84. Graveland-Bikker, J.F.; de Kruif, C.G. Unique milk protein based nanotubules: Food and nanotechnology meet. Trends Food Sci. Technol., 2006, 17, 196-203.
85. Zhao, X.; Pan, F.; Lu, J.R. Recent development of peptide self-assembly. Progr. Nat. Sci., 2008, 18, 653-660.
86. Scanlon, S.; Aggeli, A. Self-assembling peptide nanotubes. Nanotoday, 2008, 3, 22-30.
87. Yan, X.H.; He, X.; Wang, K.; Duan, L.; Cui, Y.; Li, J. Transition of cationic dipeptide nanotubes into vesicles and oligonucleotide delivery. Angew. Chem. Int., 2007, 46, 2431-2434.
88. Reches, M.; Gazit, E. Molecular self-assembly of peptide nanostructures: Mechanism of association and potential uses. Curr. Nanosci., 2006, 2, 105-111.
89. Couet, J.; Samuel, J.D.J.S.; Kopyshev, A.; Santer, S.; Biesalski, M. Peptide-polymer hybrid nanobubes. Angew. Chem. Int., 2005, 44, 3297-3301.
90. Biron, E.; Otis, F.; Meillon, J.C.; Robitaille, M.; Lamothe, J.; van Hove, P.; Cormier, M.E.; Voyer, N. Design, synthesis, and characterization of peptide nanostructures having ion channel activity. Bioorg. Med. Chem., 2004, 12, 1279-1290.
91. Colombo, G.; Soto, P.; Gazit, E. Peptide self-assembly at the nanoscale: a challenging target for computational and experimental biotechnology. Trends Biotechnol., 2007, 25, 211-218.
92. Eby, D.M.; Farrington, K.E.; Johnson, G.R. Synthesis of bioinorganic antimicrobial peptide nanoparticles with potential therapeutic properties. Biomacromolecules, 2008, 9, 2487-2494.
93. Liu, X.; Xu, K.; Wang, H.; Tan, P.K.; Fan, W.; Venkatraman, S.S.; Li, L.; Yang, Y.Y. Self-assembled cationic peptid nanoparticles as an efficient antimicrobial agent. Nature Nanotechnol., 2009, 4, 457-463.
94. Wang, Y.; Xu, K.; Liu, L.; Tan, J.P.K.; Chen, Y.; Li, Y.; Wei, Z.; Sheng, J.; Yang, Y.Y.; Li, L. The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis. Biomaterials, 2010, 31, 2874-2881.
95. Valdes-Stauber, N.; Scherer, S. Isolation and characterization of linocin M18, a bacteriocin produced by Brevibacterium linens. Appl. Environ. Microbiol., 1994, 60, 3809-3814.
96. Grau, A.; Gomez-Fernandez, J.C.; Peypoux, F.; Ortiz, A. Aggregational behaviour of aqueous dispersions of the antifungal lipopeptide iturin A. Peptides, 2001, 22, 1-5.
97. Motta, A.S.; Lorenzini, D.M.; Brandelli, A. Purification and partial characterization of an antimicrobial peptide produced by a novel Bacillus sp. isolated from the Amazon basin. Curr. Microbiol., 2007, 54, 282-286.
98. Cladera-Olivera, F.; Caron, G.R.; Brandelli, A. Bacteriocin-like substance production by Bacillus licheniformis strain P40. Lett. Appl. Microbiol., 2004, 38, 251-256.
99. Sirtori, L.R.; Cladera-Olivera, F.; Lorenzini, D.M., Tsai, S.M.; Brandelli, A. Purification and partial characterization of an antimicrobial peptide produced by Bacillus sp. strain P45, a bacterium from the Amazon basin fish Piaractus mesopotamicus. J. Gen. Appl. Microbiol., 2006, 52, 357-363.
100. Muriana, P.M.; Klaenhammer, T.R. Purification and partial characterization of lactocin F, a bacteriocin produced by Lactobacillus acidophilus 11088. Appl. Environ. Microbiol., 1991, 57, 114-121.
101. Zhang, Y.; Bai, Y.; Yan, B. Functionalized carbon nanotubes for potential medicinal applications. Drug Discovery Today, 2010, 15, 428-435.
102. Kang, S.; Pinault, M.; Pfefferle, L.D.; Elimelech, M. Single-walled carbon nanotubes exhibit strong antimicrobial activity. Langmuir, 2007, 23, 8670-8673.
103. Pangule, R.C.; Brooks, S.J.; Dinut, C.Z.; Bale, S.S.; Salmon, S.L.; Zhu, G.; Metzger, D.W.; Kane, R.S.; Dordick, J.S. Antistaphylococcal nanocomposite films based on enzyme-nanotube conjugates. ACS Nano, 2010, 4, 3993-4000.
104. Zampa, M.F.; Araujo, I.M.F.; Costa, V.; Costa, C.H.N.; Santos, J.R.; Zucolotto, V.; Eiras, C.; Leite, J.R.S.A. Leishmanicidal activity and Immobilization of dermaseptin 01 antimicrobial peptides in ultrathin films for nanomedicine applications. Nanomedicine, 2009, 5, 352-358.